Corbus Pharmaceuticals Holdings (CRBP) Shareholder's Equity Growth (3y) (2016 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Shareholder's Equity Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 133.67 Mn | 105.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 64.74% |
| Sep 30, 2025 | 30.00% |
| Jun 30, 2025 | 30.91% |
| Mar 31, 2025 | 27.62% |
| Dec 31, 2024 | 27.26% |
| Sep 30, 2024 | 24.69% |
| Jun 30, 2024 | 17.72% |
| Mar 31, 2024 | 1.95% |
| Dec 31, 2023 | -29.12% |
| Sep 30, 2023 | -77.98% |
| Jun 30, 2023 | -41.85% |
| Mar 31, 2023 | -10.15% |
| Dec 31, 2022 | 74.98% |
| Sep 30, 2022 | 12.27% |
| Jun 30, 2022 | 1.45% |
| Mar 31, 2022 | 13.07% |
| Dec 31, 2021 | 35.92% |
| Sep 30, 2021 | 21.89% |
| Jun 30, 2021 | 11.52% |
| Mar 31, 2021 | 11.77% |